Aperbio Technologies (Suzhou) Co., Ltd., founded in 2013, is a dedicated manufacturer and provider that combines innovation with cutting-edge advancements in intelligent instruments and diagnostic reagents. The company specializes in bridging the gap between life science research and clinical diagnostics, offering a wide range of products and solutions. Aperbio's expertise spans key areas such as oncology, infectious diseases, food safety, and cell and gene therapy.
Driven by the mission of "Precision for Life," Aperbio is committed to advancing global health through faster, more accurate, and highly precise diagnostic solutions. By delivering innovative tools and technologies, Aperbio aims to empower researchers and healthcare professionals to improve outcomes and transform lives.
For more information, visit https://www.aperbio.com
Company Details
- Founded
- -
- Address
- Singapore, Sg
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.aperbio.com
- Keywords
- spans key areas such as oncology.
- HQ
- Singapore
Aperbio Technologies Questions
Aperbio Technologies's website is http://www.aperbio.com
Aperbio Technologies's LinkedIn profile is https://sg.linkedin.com/company/aperbio-technologies
Aperbio Technologies's industry is
Biotechnology Research
Aperbio Technologies's top competitors are
Abbott,
Immodx Llc,
Thermo Fisher Scientific,
Stilla Technologies,
Nsg Biolabs,
Bioscience Group B.s.g,
Sniper Medical Technologies,
Co11ab Novena,
Next Level Genomics Pte Ltd,
Gold Standard Diagnostics Industrial Solutions.
Aperbio Technologies's categories are Biotechnology Research
Aperbio Technologies's founding year is 2013
